By Hasnaa Fatehi2024-02-08T00:05:00
Despite being a relatively small jurisdiction, Canada’s Medical Device Directorate (MDD) plays a dynamic role in shaping global regulations and taking a leadership role in regulatory harmonisation and convergence. From close collaborations with the US FDA to consortiums with major regulators from Brazil to Australia, the MDD works hard to ensure no interruption to health product supply and provides support for innovation and trust building with patients. Health Canada has a culture of inclusiveness, dialogue, pragmatism and global vision which are necessary values in today’s ever more stringent regulatory environment. This article introduces the regulatory framework for medical devices and discusses some key initiatives undertaken by Health Canada.
Register to continue to access industry news, podcasts and commentary plus one member-only journal article each month. You will still be able to view editorials and contents pages without restriction.
Already a TOPRA member?
Using your MyTOPRA credentials, log-in now for unlimited access to all Regulatory Rapporteur journal articles, online archive and the latest industry news and content.
LoginBecome a TOPRA member and join our global regulatory affairs community.
The peer-reviewed journal, published 11 times per year and available free to TOPRA members.
The Organisation for Professionals in Regulatory Affairs
TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org
TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70
Site powered by Webvision Cloud